EFFECT OF MASHABALAADI KWATH AND MASHABALAADI TAIL NASYA IN CERVICAL SPONDYLOSIS

A COMPARATIVE CLINICAL EVALUATION OF MASHABALAADI KWATH & MASHABALAADI TAIL NASYA IN MANYASTAMBHA W.S.R. TO CERVICAL SPONDYLOSIS

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/04/032975

Enrollment

Registered

2021-04-20

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M478- Other spondylosis

Interventions

Intervention1: MASHABALAADI TAIL NASYA: 8 DROPS IN EACH NOSTRIL IN MORNING TIME FOR 7 DAYS WITH 7 DAYS GAP IN 3 SITTINGS FOR 6 WEEKS Control Intervention1: MASHABALAADI KWATH: 50 ML KWATH ORALLY WITH

Eligibility

Inclusion criteria

Inclusion criteria: MANYASHOOL (CERVICAL REGION PAIN) STAMBHA (STIFFNESS) GAURAVA (HEAVINESS) CHIMCHIMAYANA (TINGLING SENSATION AND NUMBNESS IN FOREARM) PAIN IN NECK DURING FLEXION AND EXTENSION OF HEAD PAIN IN NECK DURING LATERAL FLEXION AND LATERAL ROTATION

Exclusion criteria

Exclusion criteria: CERVICAL VERTEBRA FRACTURE CERVICAL RIB, CERVICAL CANAL STENOSIS CONGENITAL TORTICOLLIS PATIENTS SUFFERING FROM NEURODEGENERATIVE AND POST SURGICAL CONDITION OF CERVICAL SPINE PATIENTS WITH INFECTIVE, NEOPLASTIC CONDITTION OF CERVICAL SPINE PATIENTS WITH OTHER SYSTEMIC ILLNESS LIKE CAD, CVD, DIABETES, NEOPLASM, ETC

Design outcomes

Primary

Measure	Time frame
Relief in pain, stiffness and heaviness, Relief in Tingling Sensation and numbness in forearmTimepoint: 3 weeks	—

Secondary

Measure	Time frame
Relief in pain, stiffness and heaviness, Improvement during flexion and extension of HeadTimepoint: 6 weeks	—

Countries

India

Contacts

Public ContactDR VIPUL VIKRAM

GOVERNMENT P.G. AYURVEDA COLLEGE AND HOSPITAL, VARANASI

rachananigam19@gmail.com8948732899

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026